![Preoperative s-CEA levels and disease-free survival rate of stage III... | Download Scientific Diagram Preoperative s-CEA levels and disease-free survival rate of stage III... | Download Scientific Diagram](https://www.researchgate.net/publication/7660990/figure/fig2/AS:203056043040780@1425423741964/Preoperative-s-CEA-levels-and-disease-free-survival-rate-of-stage-III-colorectal-cancer.png)
Preoperative s-CEA levels and disease-free survival rate of stage III... | Download Scientific Diagram
![IJMS | Free Full-Text | Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer IJMS | Free Full-Text | Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer](https://www.mdpi.com/ijms/ijms-24-06753/article_deploy/html/images/ijms-24-06753-g001.png)
IJMS | Free Full-Text | Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer
![Dye sensitized photoelectrochemical immunosensor for the tumor marker CEA by using a flower-like 3D architecture prepared from graphene oxide and MoS2 | SpringerLink Dye sensitized photoelectrochemical immunosensor for the tumor marker CEA by using a flower-like 3D architecture prepared from graphene oxide and MoS2 | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00604-018-2853-z/MediaObjects/604_2018_2853_Sch1_HTML.png)
Dye sensitized photoelectrochemical immunosensor for the tumor marker CEA by using a flower-like 3D architecture prepared from graphene oxide and MoS2 | SpringerLink
![PDF] Diagnostic Value of a Panel of Tumor Markers as a Part of a Diagnostic Work-Up for Ascites of Unknown Etiology | Semantic Scholar PDF] Diagnostic Value of a Panel of Tumor Markers as a Part of a Diagnostic Work-Up for Ascites of Unknown Etiology | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6824ffeb999b927b99ef8b3b3ec2a4cc9987909e/4-Table2-1.png)
PDF] Diagnostic Value of a Panel of Tumor Markers as a Part of a Diagnostic Work-Up for Ascites of Unknown Etiology | Semantic Scholar
![CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) - CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419347507-gr1.jpg)
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -
![Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer](https://f6publishing.blob.core.windows.net/6eea788a-8910-4b98-9e9d-5f0d78ab8b87/WJGS-14-1272-g003.png)
Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer
![Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations | BMC Cancer | Full Text Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-017-3474-3/MediaObjects/12885_2017_3474_Fig1_HTML.gif)
Elevated serum CEA levels are associated with the explosive progression of lung adenocarcinoma harboring EGFR mutations | BMC Cancer | Full Text
![Serum Cytokeratin Fragment 21.1 (CYFRA 21.1) as Tumour Marker for Breast Cancer: Comparison with Carbohydrate Antigen 15.3 (CA 15.3) and Carcinoembryonic Antigen (CEA) | Semantic Scholar Serum Cytokeratin Fragment 21.1 (CYFRA 21.1) as Tumour Marker for Breast Cancer: Comparison with Carbohydrate Antigen 15.3 (CA 15.3) and Carcinoembryonic Antigen (CEA) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1e3e328c0b1e0106348a132f1fc2f18c51ebd3bd/3-Table3-1.png)
Serum Cytokeratin Fragment 21.1 (CYFRA 21.1) as Tumour Marker for Breast Cancer: Comparison with Carbohydrate Antigen 15.3 (CA 15.3) and Carcinoembryonic Antigen (CEA) | Semantic Scholar
![Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy | Anticancer Research Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/36/3/1041/F1.large.jpg)
Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy | Anticancer Research
Site-Specific N-Linked Glycosylation Analysis of Human Carcinoembryonic Antigen by Sheathless Capillary Electrophoresis–Tandem Mass Spectrometry | Journal of Proteome Research
![CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) - CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419347507-gr2.jpg)
CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial) -
![Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancer | Scientific Reports Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep34131/MediaObjects/41598_2016_Article_BFsrep34131_Fig1_HTML.jpg)
Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancer | Scientific Reports
Early serum tumor marker levels after fourteen days of tyrosine kinase inhibitor targeted therapy predicts outcomes in patients with advanced lung adenocarcinoma | PLOS ONE
![IJMS | Free Full-Text | The Effectiveness of Glutathione Redox Status as a Possible Tumor Marker in Colorectal Cancer IJMS | Free Full-Text | The Effectiveness of Glutathione Redox Status as a Possible Tumor Marker in Colorectal Cancer](https://www.mdpi.com/ijms/ijms-22-06183/article_deploy/html/images/ijms-22-06183-g001.png)